<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36359409</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>10</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2889</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines10112889</ELocationID><Abstract><AbstractText>Introduction: COVID-19 survivors reveal an increased long-term risk for cardiovascular disease. Biomarkers like troponins and sST-2 improve stratification of cardiovascular risk. Nevertheless, their prognostic value for identifying long-term cardiovascular risk after having survived COVID-19 has yet to be evaluated. Methods: In this single-center study, admission serum biomarkers of sST-2 and hs-TnI in a single cohort of 251 hospitalized COVID-19 survivors were evaluated. Concentrations were correlated with major cardiovascular events (MACE) defined as cardiovascular death and/or need for cardiovascular hospitalization during follow-up after hospital discharge [FU: 415 days (403; 422)]. Results: MACE was a frequent finding during FU with an incidence of 8.4% (cardiovascular death: 2.8% and/or need for cardiovascular hospitalization: 7.2%). Both biomarkers were reliable indicators of MACE (hs-TnI: sensitivity = 66.7% &amp; specificity = 65.7%; sST-2: sensitivity = 33.3% &amp; specificity = 97.4%). This was confirmed in a multivariate proportional-hazards analysis: besides age (HR = 1.047, 95% CI = 1.012&#x2212;1.084, p = 0.009), hs-TnI (HR = 4.940, 95% CI = 1.904&#x2212;12.816, p = 0.001) and sST-2 (HR = 10.901, 95% CI = 4.509&#x2212;29.271, p &lt; 0.001) were strong predictors of MACE. The predictive value of the model was further improved by combining both biomarkers with the factor age (concordance index hs-TnI + sST2 + age = 0.812). Conclusion: During long-term FU, hospitalized COVID-19 survivors, hs-TnI and sST-2 at admission, were strong predictors of MACE, indicating both proteins to be involved in post-acute sequelae of COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fiedler</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2626-3098</Identifier><AffiliationInfo><Affiliation>University Clinic for Internal Medicine II, Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Cardiology, Nephrology and Intensive Care Medicine, Hospital Wiener Neustadt, 2700 Wiener Neustadt, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motloch</LastName><ForeName>Lukas J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>University Clinic for Internal Medicine II, Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jirak</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Clinic for Internal Medicine II, Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gumerov</LastName><ForeName>Ruslan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Diseases, Bashkir State Medical University, Lenin Str. 3, 450008 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davtyan</LastName><ForeName>Paruir</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Diseases, Bashkir State Medical University, Lenin Str. 3, 450008 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gareeva</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Diseases, Bashkir State Medical University, Lenin Str. 3, 450008 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakman</LastName><ForeName>Irina</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9876-9202</Identifier><AffiliationInfo><Affiliation>Department of Internal Diseases, Bashkir State Medical University, Lenin Str. 3, 450008 Ufa, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scientific Laboratory for the Socio-Economic Region Problems Investigation, Ufa University of Science and Technology, Zaki Validi Str. 32, 450076 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tataurov</LastName><ForeName>Alexandr</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Ufa University of Science and Technology, Zaki Validi Str. 32, 450076 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lasinova</LastName><ForeName>Gulnaz</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Diseases, Bashkir State Medical University, Lenin Str. 3, 450008 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavlov</LastName><ForeName>Valentin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Urology, Bashkir State Medical University, Lenin Str. 3, 450008 Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauptmann</LastName><ForeName>Laurenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University Clinic for Internal Medicine II, Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kopp</LastName><ForeName>Kristen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7265-8560</Identifier><AffiliationInfo><Affiliation>University Clinic for Internal Medicine II, Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoppe</LastName><ForeName>Uta C</ForeName><Initials>UC</Initials><AffiliationInfo><Affiliation>University Clinic for Internal Medicine II, Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtenauer</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Clinic for Internal Medicine II, Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistulli</LastName><ForeName>Rudin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology I, Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, 48149 Muenster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieplinger</LastName><ForeName>Anna-Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Nursing Science Program, Institute for Nursing Science and Practice, Paracelsus Medical University, 5020 Salzburg, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, Johannes Kepler University Linz, 4040 Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zagidullin</LastName><ForeName>Naufal</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2386-6707</Identifier><AffiliationInfo><Affiliation>Department of Internal Diseases, Bashkir State Medical University, Lenin Str. 3, 450008 Ufa, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22-25-00019</GrantID><Agency>Russian Science Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 3</Keyword><Keyword MajorTopicYN="N">MACE 1</Keyword><Keyword MajorTopicYN="N">cardiovascular death 2</Keyword><Keyword MajorTopicYN="N">long COVID-19 5</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 sequelae 4</Keyword><Keyword MajorTopicYN="N">sST-2 7</Keyword><Keyword MajorTopicYN="N">troponin 6</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36359409</ArticleId><ArticleId IdType="pmc">PMC9687975</ArticleId><ArticleId IdType="doi">10.3390/biomedicines10112889</ArticleId><ArticleId IdType="pii">biomedicines10112889</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chalmers J.D., Crichton M.L., Goeminne P.C., Cao B., Humbert M., Shteinberg M., Antoniou K.M., Ulrik C.S., Parks H., Wang C., et al. Management of Hospitalised Adults with Coronavirus Disease 2019 (COVID-19): A European Respiratory Society Living Guideline. Eur. Respir. J. 2021;57:2100048. doi: 10.1183/13993003.00048-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00048-2021</ArticleId><ArticleId IdType="pmc">PMC7947358</ArticleId><ArticleId IdType="pubmed">33692120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., et al. Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. Lancet. 2020;395:565&#x2013;574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X., Chen K., Zou J., Han P., Hao J., Han Z. Single-Cell RNA-Seq Data Analysis on the Receptor ACE2 Expression Reveals the Potential Risk of Different Human Organs Vulnerable to 2019-NCoV Infection. Front. Med. 2020;14:185&#x2013;192. doi: 10.1007/s11684-020-0754-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-Term Cardiovascular Outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Jirak P., van Almsick V., Dimitroulis D., Mirna M., Seelmaier C., Shomanova Z., Wernly B., Semo D., Dankl D., Mahringer M., et al. Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis. Front. Med. 2022;9:808221. doi: 10.3389/fmed.2022.808221.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.808221</ArticleId><ArticleId IdType="pmc">PMC8847392</ArticleId><ArticleId IdType="pubmed">35186995</ArticleId></ArticleIdList></Reference><Reference><Citation>Jirak P., Shomanova Z., Larbig R., Dankl D., Frank N., Seelmaier C., Butkiene D., Lichtenauer M., Mirna M., Strohmer B., et al. Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe Pneumonia. Front. Cardiovasc. Med. 2021;8:ehab724.0287. doi: 10.3389/fcvm.2021.763827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.763827</ArticleId><ArticleId IdType="pmc">PMC8652060</ArticleId><ArticleId IdType="pubmed">34901224</ArticleId></ArticleIdList></Reference><Reference><Citation>Jirak P., Larbig R., Shomanova Z., Fr&#xf6;b E.J., Dankl D., Torgersen C., Frank N., Mahringer M., Butkiene D., Haake H., et al. Myocardial Injury in Severe COVID-19 Is Similar to Pneumonias of Other Origin: Results from a Multicentre Study. ESC Heart Fail. 2021;8:37&#x2013;46. doi: 10.1002/ehf2.13136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13136</ArticleId><ArticleId IdType="pmc">PMC7835505</ArticleId><ArticleId IdType="pubmed">33350605</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagidullin N.S., Motloch L.J., Musin T.I., Bagmanova Z.A., Lakman I.A., Tyurin A.V., Gumerov R.M., Enikeev D., Cai B., Gareeva D.F., et al. J-Waves in Acute COVID-19: A Novel Disease Characteristic and Predictor of Mortality? PLoS ONE. 2021;16:e0257982. doi: 10.1371/journal.pone.0257982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257982</ArticleId><ArticleId IdType="pmc">PMC8516278</ArticleId><ArticleId IdType="pubmed">34648510</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D., Ballouz T., Anagnostopoulos A., Aschmann H.E., Domenghino A., Fehr J.S., Puhan M.A. Burden of Post-COVID-19 Syndrome and Implications for Healthcare Service Planning: A Population-Based Cohort Study. PLoS ONE. 2021;16:e0254523. doi: 10.1371/journal.pone.0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising Long COVID: A Living Systematic Review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate S.M., Mantefardo B., Nega S., Chekole Y.A., Basu B., Ali S.A., Taddesse M. Global Burden of Acute Myocardial Injury Associated with COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression. Ann. Med. Surg. 2021;68:102594. doi: 10.1016/j.amsu.2021.102594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.102594</ArticleId><ArticleId IdType="pmc">PMC8316689</ArticleId><ArticleId IdType="pubmed">34336202</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohar A., Chong J.P.C., Liew O.W., den Ruijter H., de Kleijn D.P.V., Sim D., Yeo D.P.S., Ong H.Y., Jaufeerally F., Leong G.K.T., et al. The Prognostic Value of Highly Sensitive Cardiac Troponin Assays for Adverse Events in Men and Women with Stable Heart Failure and a Preserved vs. Reduced Ejection Fraction. Eur. J. Heart Fail. 2017;19:1638&#x2013;1647. doi: 10.1002/ejhf.911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.911</ArticleId><ArticleId IdType="pubmed">28849609</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F., Gong W., Liu X., Liang J., Zhao Q., et al. Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G., Lavie C.J., Sanchis-Gomar F. Cardiac Troponin I in Patients with Coronavirus Disease 2019 (COVID-19): Evidence from a Meta-Analysis. Prog. Cardiovasc. Dis. 2020;63:390&#x2013;391. doi: 10.1016/j.pcad.2020.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7127395</ArticleId><ArticleId IdType="pubmed">32169400</ArticleId></ArticleIdList></Reference><Reference><Citation>Casula M., Montecucco F., Bonaventura A., Liberale L., Vecchi&#xe9; A., Dallegri F., Carbone F. Update on the Role of Pentraxin 3 in Atherosclerosis and Cardiovascular Diseases. Vascul. Pharmacol. 2017;99:1&#x2013;12. doi: 10.1016/j.vph.2017.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2017.10.003</ArticleId><ArticleId IdType="pubmed">29051088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccone M.M., Cortese F., Gesualdo M., Riccardi R., Di Nunzio D., Moncelli M., Iacoviello M., Scicchitano P. A Novel Cardiac Bio-Marker: ST2: A Review. Molecules. 2013;18:15314&#x2013;15328. doi: 10.3390/molecules181215314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules181215314</ArticleId><ArticleId IdType="pmc">PMC6270545</ArticleId><ArticleId IdType="pubmed">24335613</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagidullin N., Motloch L.J., Gareeva D., Hamitova A., Lakman I., Krioni I., Popov D., Zulkarneev R., Paar V., Kopp K., et al. Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction. J. Clin. Med. 2020;9:550. doi: 10.3390/jcm9020550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020550</ArticleId><ArticleId IdType="pmc">PMC7073894</ArticleId><ArticleId IdType="pubmed">32085400</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwahana H., Yanagisawa K., Ito-Kosaka A., Kuroiwa K., Tago K., Komatsu N., Katashima R., Itakura M., Tominaga S.I. Different Promoter Usage and Multiple Transcription Initiation Sites of the Interleukin-1 Receptor-Related Human ST2 Gene in UT-7 and TM12 Cells. Eur. J. Biochem. 1999;264:397&#x2013;406. doi: 10.1046/j.1432-1327.1999.00615.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1327.1999.00615.x</ArticleId><ArticleId IdType="pubmed">10491084</ArticleId></ArticleIdList></Reference><Reference><Citation>Zizzo G., Cohen P.L. Imperfect Storm: Is Interleukin-33 the Achilles Heel of COVID-19? Lancet Rheumatol. 2020;2:e779&#x2013;e790. doi: 10.1016/S2665-9913(20)30340-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30340-4</ArticleId><ArticleId IdType="pmc">PMC7546716</ArticleId><ArticleId IdType="pubmed">33073244</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y., Ge Y., Sun J. IL-33 in COVID-19: Friend or Foe? Cell. Mol. Immunol. 2021;18:1602&#x2013;1604. doi: 10.1038/s41423-021-00685-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00685-w</ArticleId><ArticleId IdType="pmc">PMC8108013</ArticleId><ArticleId IdType="pubmed">33972738</ArticleId></ArticleIdList></Reference><Reference><Citation>Miftode R.S., Petri&#x219; A.O., Aursulesei V.O., Cianga C., Costache I.I., Mitu O., Miftode I.L., &#x218;erban I.L. The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19. Diagnostics. 2021;11:175. doi: 10.3390/diagnostics11020175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11020175</ArticleId><ArticleId IdType="pmc">PMC7911622</ArticleId><ArticleId IdType="pubmed">33530550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z., Hong X.Y., Li Y., Chen W., Ye G., Li Y., Luo Y. Serum-Soluble ST2 as a Novel Biomarker Reflecting Inflammatory Status and Illness Severity in Patients with COVID-19. Biomark. Med. 2020;14:1619&#x2013;1629. doi: 10.2217/bmm-2020-0410.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2020-0410</ArticleId><ArticleId IdType="pubmed">33336592</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Marteles M., Rubio-Gracia J., Pe&#xf1;a-Fresneda N., Garc&#xe9;s-Horna V., Gracia-Tello B., Mart&#xed;nez-Lostao L., Crespo-Azn&#xe1;rez S., P&#xe9;rez-Calvo J.I., Gim&#xe9;nez-L&#xf3;pez I. Early Measurement of Blood Sst2 Is a Good Predictor of Death and Poor Outcomes in Patients Admitted for Covid-19 Infection. J. Clin. Med. 2021;10:3534. doi: 10.3390/jcm10163534.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163534</ArticleId><ArticleId IdType="pmc">PMC8396994</ArticleId><ArticleId IdType="pubmed">34441830</ArticleId></ArticleIdList></Reference><Reference><Citation>Russian Current National COVID-19 Guidelines Version 7. 2020.  [(accessed on 3 July 2020)].  Available online:  https://Edu.Rosminzdrav.Ru/Fileadmin/User_upload/Specialists/COVID-19/MR_COVID-19_v7.Pdf.</Citation></Reference><Reference><Citation>Unified Digital Platform&#x2014;Republican Medical Information Analytical System of the Republic of Bashkortostan.  [(accessed on 1 September 2022)].  Available online:  https://Swantest.Promedweb.Ru.</Citation></Reference><Reference><Citation>Priori S.G., Blomstrom-Lundqvist C., Mazzanti A., Bloma N., Borggrefe M., Camm J., Elliott P.M., Fitzsimons D., Hatala R., Hindricks G., et al. 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) Eur. Heart J. 2015;36:1601&#x2013;1687. doi: 10.1093/europace/euv319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euv319</ArticleId><ArticleId IdType="pubmed">25841872</ArticleId></ArticleIdList></Reference><Reference><Citation>Emdin M., Aimo A., Vergaro G., Bayes-Genis A., Lup&#xf3;n J., Latini R., Meessen J., Anand I.S., Cohn J.N., Gravning J., et al. SST2 Predicts Outcome in Chronic Heart Failure Beyond NT-ProBNP and High-Sensitivity Troponin T. J. Am. Coll. Cardiol. 2018;72:2309&#x2013;2320. doi: 10.1016/j.jacc.2018.08.2165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.2165</ArticleId><ArticleId IdType="pubmed">30384887</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaggin H.K., Szymonifka J., Bhardwaj A., Belcher A., de Berardinis B., Motiwala S., Wang T.J., Januzzi J.L. Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients with Chronic Heart Failure. JACC Heart Fail. 2014;2:65&#x2013;72. doi: 10.1016/j.jchf.2013.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2013.10.005</ArticleId><ArticleId IdType="pubmed">24622120</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards A.M. ST2 and Prognosis in Chronic Heart Failure. J. Am. Coll. Cardiol. 2018;72:2321&#x2013;2323. doi: 10.1016/j.jacc.2018.08.2164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.2164</ArticleId><ArticleId IdType="pubmed">30384888</ArticleId></ArticleIdList></Reference><Reference><Citation>Omland T., Pfeffer M.A., Solomon S.D., de Lemos J.A., R&#xf8;sj&#xf8; H., Benth J.&#x160;., Maggioni A., Domanski M.J., Rouleau J.L., Sabatine M.S., et al. Prognostic Value of Cardiac Troponin I Measured with a Highly Sensitive Assay in Patients with Stable Coronary Artery Disease. J. Am. Coll. Cardiol. 2013;61:1240&#x2013;1249. doi: 10.1016/j.jacc.2012.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.12.026</ArticleId><ArticleId IdType="pubmed">23414791</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmakis D., Mueller C., Apple F.S. High-Sensitivity Cardiac Troponin Assays for Cardiovascular Risk Stratification in the General Population. Eur. Heart J. 2020;41:4050&#x2013;4056. doi: 10.1093/eurheartj/ehaa083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa083</ArticleId><ArticleId IdType="pubmed">32077940</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenberg S., Salomaa V., Makarova N., Ojeda F., Wild P., Lackner K.J., J&#xf8;rgensen T., Thorand B., Peters A., Nauck M., et al. Troponin I and Cardiovascular Risk Prediction in the General Population: The BiomarCaRE Consortium. Eur. Heart J. 2016;37:2428&#x2013;2437. doi: 10.1093/eurheartj/ehw172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw172</ArticleId><ArticleId IdType="pmc">PMC4982535</ArticleId><ArticleId IdType="pubmed">27174290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Xu C., Zhao R., Cao Z. Diagnostic Value of SST2 in Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Front. Cardiovasc. Med. 2021;8:764. doi: 10.3389/fcvm.2021.697837.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.697837</ArticleId><ArticleId IdType="pmc">PMC8342767</ArticleId><ArticleId IdType="pubmed">34368254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J.E., Sritara P., Defilippi C.R., Wang T.J. Soluble ST2 Testing in the General Population. Am. J. Cardiol. 2015;115:22B&#x2013;25B. doi: 10.1016/j.amjcard.2015.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.01.036</ArticleId><ArticleId IdType="pubmed">25665763</ArticleId></ArticleIdList></Reference><Reference><Citation>Raschke R.A., Rangan P., Agarwal S., Uppalapu S., Sher N., Curry S.C., Heise C.W. COVID-19 Time of Intubation Mortality Evaluation (C-TIME): A System for Predicting Mortality of Patients with COVID-19 Pneumonia at the Time They Require Mechanical Ventilation. PLoS ONE. 2022;17:e0270193. doi: 10.1371/journal.pone.0270193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270193</ArticleId><ArticleId IdType="pmc">PMC9258832</ArticleId><ArticleId IdType="pubmed">35793312</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Macho J., Ryan P., Valencia J., P&#xe9;rez-Butrague&#xf1;o M., Jim&#xe9;nez E., Font&#xe1;n-Vela M., Izquierdo-Garc&#xed;a E., Fernandez-Jimenez I., &#xc1;lvaro-Alonso E., Lazaro A., et al. The Pandemyc Score. An Easily Applicable and Interpretable Model for Predicting Mortality Associated with COVID-19. J. Clin. Med. 2020;9:3066. doi: 10.3390/jcm9103066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9103066</ArticleId><ArticleId IdType="pmc">PMC7598151</ArticleId><ArticleId IdType="pubmed">32977606</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Guti&#xe9;rrez B., del Toro M.D., Borobia A.M., Carcas A., Jarr&#xed;n I., Yllescas M., Ryan P., Pach&#xf3;n J., Carratal&#xe0; J., Berenguer J., et al. Identification and Validation of Clinical Phenotypes with Prognostic Implications in Patients Admitted to Hospital with COVID-19: A Multicentre Cohort Study. Lancet Infect. Dis. 2021;21:783&#x2013;792. doi: 10.1016/S1473-3099(21)00019-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00019-0</ArticleId><ArticleId IdType="pmc">PMC7906623</ArticleId><ArticleId IdType="pubmed">33636145</ArticleId></ArticleIdList></Reference><Reference><Citation>Rywik T.M., Janas J., Klisiewicz A., Leszek P., Sobieszcza&#x144;ska-Ma&#x142;ek M., Kurjata P., Rozentryt P., Korewicki J., Jerzak-Wodzy&#x144;ska G., Zieli&#x144;ski T. Prognostic Value of Novel Biomarkers Compared with Detailed Biochemical Evaluation in Patients with Heart Failure. Pol. Arch. Med. Wewn. 2015;125:434&#x2013;442. doi: 10.20452/pamw.2884.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.2884</ArticleId><ArticleId IdType="pubmed">26020442</ArticleId></ArticleIdList></Reference><Reference><Citation>Mebazaa A., Di Somma S., Maisel A.S., Bayes-Genis A. ST2 and Multimarker Testing in Acute Decompensated Heart Failure. Am. J. Cardiol. 2015;115:38B&#x2013;43B. doi: 10.1016/j.amjcard.2015.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.01.039</ArticleId><ArticleId IdType="pubmed">25697917</ArticleId></ArticleIdList></Reference><Reference><Citation>Shams-Vahdati S., Vand-Rajavpour Z., Paknezhad S.-P., Piri R., Moghaddasi-Ghezeljeh E., Mirabolfathi S., Naghavi-Behzad M. Cost-Effectiveness of Cardiac Biomarkers as Screening Test in Acute Chest Pain. J. Cardiovasc. Thorac. Res. 2014;6:29&#x2013;33. doi: 10.5681/jcvtr.2014.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.5681/jcvtr.2014.006</ArticleId><ArticleId IdType="pmc">PMC3992729</ArticleId><ArticleId IdType="pubmed">24753829</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontos M.C., Turlington J.S. High-Sensitivity Troponins in Cardiovascular Disease. Curr. Cardiol. Rep. 2020;22:30. doi: 10.1007/s11886-020-01279-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-020-01279-0</ArticleId><ArticleId IdType="pubmed">32232671</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A., White H.D., Mickley H., Crea F., Van De Werf F., et al. Fourth Universal Definition of Myocardial Infarction (2018) Eur. Heart J. 2019;40:237&#x2013;269. doi: 10.1093/eurheartj/ehy462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy462</ArticleId><ArticleId IdType="pubmed">30165617</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C., Leone O., Rizzo S., De Gaspari M., Van Der Wal A.C., Aubry M.C., Bois M.C., Lin P.T., Maleszewski J.J., Stone J.R. Pathological Features of COVID-19-Associated Myocardial Injury: A Multicentre Cardiovascular Pathology Study. Eur. Heart J. 2020;41:3827&#x2013;3835. doi: 10.1093/eurheartj/ehaa664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa664</ArticleId><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual-Figal D.A., Januzzi J.L. The Biology of ST2: The International ST2 Consensus Panel. Am. J. Cardiol. 2015;115:3B&#x2013;7B. doi: 10.1016/j.amjcard.2015.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.01.034</ArticleId><ArticleId IdType="pubmed">25665766</ArticleId></ArticleIdList></Reference><Reference><Citation>Altara R., Ghali R., Mallat Z., Cataliotti A., Booz G.W., Zouein F.A. Conflicting Vascular and Metabolic Impact of the IL-33/SST2 Axis. Cardiovasc. Res. 2018;114:1578&#x2013;1594. doi: 10.1093/cvr/cvy166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvy166</ArticleId><ArticleId IdType="pubmed">29982301</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanczak M.A., Sanin D.E., Apostolova P., Nerz G., Lampaki D., Hofmann M., Steinmann D., Krohn-Grimberghe M., Thimme R., Mittler G., et al. IL-33 Expression in Response to SARS-CoV-2 Correlates with Seropositivity in COVID-19 Convalescent Individuals. Nat. Commun. 2021;12:2133. doi: 10.1038/s41467-021-22449-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22449-w</ArticleId><ArticleId IdType="pmc">PMC8035172</ArticleId><ArticleId IdType="pubmed">33837219</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg D.D., Freedman B.L., Bonaca M.P., Jarolim P., Scirica B.M., Goodrich E.L., Sabatine M.S., Morrow D.A. Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients with Atherothrombotic Disease: A Nested Biomarker Study from Tra 2&#xb0;p-Timi 50. J. Am. Heart Assoc. 2021;10:e018673. doi: 10.1161/JAHA.120.018673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.018673</ArticleId><ArticleId IdType="pmc">PMC8200769</ArticleId><ArticleId IdType="pubmed">33884889</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirna M., Rohm I., Jirak P., Wernly B., B&#xe4;z L., Paar V., Kretzschmar D., Hoppe U.C., Schulze P.C., Lichtenauer M., et al. Analysis of Novel Cardiovascular Biomarkers in Patients with Pulmonary Hypertension (PH) Heart Lung Circ. 2020;29:337&#x2013;344. doi: 10.1016/j.hlc.2019.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2019.03.004</ArticleId><ArticleId IdType="pubmed">31327702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>